Media o nas
PGT-M
PGT-M (Preimplantation Genetic Testing for monogenic / single gene disorders), formerly known as PGD for monogenic diseases, is a genetic test for disorders in single genes (monogenic diseases). It involves the assessment of the genetic material of embryos formed during the in vitro procedure. The purpose of PGT-M is to reduce the risk of transferring a specific genetic disease to a child. The identification of mutations and the transfer of healthy embryos increases the chances of pregnancy and the birth of a healthy child.
Who should perform the PGT-M (PGD) test?
The PGT-M test is recommended for couples who are at high risk of transferring a specific defect of a single gene. The test should therefore be considered especially when:
- You and your partner are carriers of autosomal recessive disorder (eg cystic fibrosis),
- You or your partner are carriers of a sex-coupled disease (eg Duchenne muscular dystrophy),
- You or your partner are carriers of an autosomal dominant disease (eg Huntington's disease),
- You or your partner have a mutation associated with an inherited cancer syndrome (genes related to DNA repair),
- You have a child with a single gene defect,
- The cause of the miscarriage was a defect of a single gene in the fetus.
Why is it worth to perform the PGT-M (PGD) test?
- The study allows the selection of a healthy and best-promising embryo for transfer.
- The transfer of a healthy embryo increases the chance of pregnancy and the birth of a healthy child and reduces the risk of miscarriage.